DDW: Dual method aids removal of right colon polyps

Share this content:
Colorectal cancer rates increasing for U.S. adults under 50
Colorectal cancer rates increasing for U.S. adults under 50

(HealthDay News) -- Laparoscopic-assisted colonoscopy with polypectomy (LACP) may be an effective alternative to laparoscopic hemicolectomy (LHC) for difficult-to-remove polyps in the right colon, according to research presented at the annual Digestive Disease Week, held from May 3 to 6 in Chicago.

Jonathan Buscaglia, M.D., of the Stony Brook University School of Medicine in New York City, and colleagues randomly assigned patients to LACP (14 patients) or LHC (14 patients) for the removal of unresectable polyps in the right colon.

The researchers found that removal of polyps in the right colon by LACP was technically successful in 92.9 percent of patients, with one conversion to LHC. Removal of polyps in the right colon by LHC was technically successful in 71.4 percent of patients with four conversions to laparotomy. Compared with patients undergoing LACP, those undergoing LHC had a longer mean operating time (179 versus 95 minutes; P = 0.001), greater estimated blood loss (63 versus 13 mL; P = 0.001), and greater intravenous fluid requirements (3.1 versus 2.1 L; P = 0.049). Patients undergoing LHC, compared with those undergoing LACP, were slower to pass flatus (2.88 versus 1.44 days; P = 0.002), resume eating solid food (3.94 versus 1.69 days; P < 0.001), and be discharged from the hospital (4.94 versus 2.63 days; P < 0.001). No significant differences between the groups were observed for postoperative complications, readmissions, or repeat operations.

"About 25 percent of patients undergoing colonoscopy require polyp removal, and a significant proportion of these patients have large polyps that cannot be easily removed by standard advanced colonoscopic techniques," Buscaglia said in a statement. "These findings suggest that we may need to tailor our surgical approach to ensure every patient receives the best care possible, regardless of polyp removal difficulty."

Press Release
More Information

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs